Literature DB >> 16523257

Changing epidemiology of methicillin-resistant Staphylococcus aureus and effects on cross-transmission in a teaching hospital.

F X Lescure1, M Biendo, Y Douadi, J L Schmit, M Eveillard.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16523257     DOI： 10.1007/s10096-006-0104-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

Review 1.  Can antibiotic-resistant nosocomial infections be controlled?

Authors:  B M Farr; C D Salgado; T B Karchmer; R J Sherertz
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

2.  Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage.

Authors:  A Scanvic; L Denic; S Gaillon; P Giry; A Andremont; J C Lucet
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

3.  Impact of screening for MRSA carriers at hospital admission on risk-adjusted indicators according to the imported MRSA colonization pressure.

Authors:  M Eveillard; E Lancien; G Barnaud; N Hidri; S Gaba; J A Benlolo; M-L Joly-Guillou
Journal:  J Hosp Infect       Date:  2005-03       Impact factor: 3.926

4.  Consideration of age at admission for selective screening to identify methicillin-resistant Staphylococcus aureus carriers to control dissemination in a medical ward.

Authors:  Matthieu Eveillard; Emmanuel Mortier; Evelyne Lancien; François-Xavier Lescure; Jean-Luc Schmit; Guilène Barnaud; Nelly Lenfant; Philippe Vinceneux; Marie-Laure Joly-Guillou
Journal:  Am J Infect Control       Date:  2006-04       Impact factor: 2.918

5.  Surveillance and control of methicillin-resistant Staphylococcus aureus infections in French hospitals.

Authors:  D Lepelletier; H Richet
Journal:  Infect Control Hosp Epidemiol       Date:  2001-11       Impact factor: 3.254

6.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

7.  "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit.

Authors:  J Merrer; F Santoli; C Appéré de Vecchi; B Tran; B De Jonghe; H Outin
Journal:  Infect Control Hosp Epidemiol       Date:  2000-11       Impact factor: 3.254

8.  Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.

Authors:  Cassandra D Salgado; Barry M Farr; David P Calfee
Journal:  Clin Infect Dis       Date:  2003-01-03       Impact factor: 9.079

Review 9.  The changing epidemiology of Staphylococcus aureus?

Authors:  H F Chambers
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883
  9 in total
  5 in total

Review 1.  Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens.

Authors:  Biswadeep Das; Chayna Sarkar; Debasmita Das; Amit Gupta; Arnav Kalra; Shubham Sahni
Journal:  Ther Adv Infect Dis       Date:  2017-03-08

2.  Predicting methicillin resistance among community-onset Staphylococcus aureus bacteremia patients with prior healthcare-associated exposure.

Authors:  S-Y Chen; W-C Chiang; M H-M Ma; P-R Hsueh; S-C Chang; C-C Fang; S-C Chen; W-J Chen; W-C Chie; M-S Lai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-19       Impact factor: 3.267

3.  Molecular and phenotypic characterization of methicillin-resistant Staphylococcus aureus isolates from a tertiary hospital in the Philippines.

Authors:  Demetrio L Valle; Phyllis Anne P Paclibare; Esperanza C Cabrera; Windell L Rivera
Journal:  Trop Med Health       Date:  2016-03-14

4.  Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.

Authors:  Philip Van De Griend; Loreen A Herwaldt; Bret Alvis; Mary DeMartino; Kristopher Heilmann; Gary Doern; Patricia Winokur; Diana DeSalvo Vonstein; Daniel Diekema
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

5.  Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.

Authors:  Yang Peng; Xiaohua Ye; Ying Li; Tao Bu; Xiaofeng Chen; Jiaqi Bi; Junli Zhou; Zhenjiang Yao
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.